Trials / Unknown
UnknownNCT06360679
Clinical Feasibility Study of the BariTon™ System in Obese or Overweight Patients.
Clinical Feasibility Study of the BariTon™ System in Obese or Overweight (BMI > 27) Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- BariaTek Medical · Industry
- Sex
- All
- Age
- 25 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Safety and efficacy evaluation of the BariTon™, BariaTek Medical gastric restriction and biliodigestive diversion device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endoscopic gastric restriction and biliodigestive diversion | The BariTon™ is endoscopically implanted and retrieved once treatment is completed |
Timeline
- Start date
- 2024-01-29
- Primary completion
- 2024-10-01
- Completion
- 2025-06-01
- First posted
- 2024-04-11
- Last updated
- 2024-04-11
Locations
2 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT06360679. Inclusion in this directory is not an endorsement.